ReviewMiddle East African journal of ophthalmology
Advanced glaucoma: management pearls.
Review in Middle East African journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Portable devices for diagnosis and monitoring of glaucoma: a scoping review protocol.BMJ open · 2024Article
- Cost-effectiveness of polygenic risk profiling for primary open-angle glaucoma in the United Kingdom and Australia.Eye (London, England) · 2023Article
- Vision-Related Quality of Life and Associated Factors Among an Adult Population with Glaucoma Attending a Comprehensive Specialized Hospital, Northwest Ethiopia.Clinical ophthalmology (Auckland, N.Z.) · 2023Article
- The role of optical coherence tomography angiography in moderate and advanced primary open-angle glaucoma.International ophthalmology · 2022Article
- Assessment of Risk Factors for Advanced Open Angle Glaucoma Presentation among Patients Visiting Jimma University Medical Center, Jimma, Ethiopia.Ethiopian journal of health sciences · 2022Article
- Combined Visco-Trab operation: A dual filtration pathway for management of advanced glaucoma-midterm results.International ophthalmology · 2021Article
- Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma.Clinical ophthalmology (Auckland, N.Z.) · 2021Article
- Comparison of complications after Ahmed versus Baerveldt implant in glaucoma patients: one year follow-up.International journal of ophthalmology · 2020Article
- Article
- Role of trabeculectomy in advanced glaucoma: Whether we stand to consider it a bane or a boon today?International ophthalmology · 2019Article
- The impact of glaucoma on quality of life in Ethiopia: a case-control study.BMC ophthalmology · 2017Article
- Restoration of Aqueous Humor Outflow Following Transplantation of iPSC-Derived Trabecular Meshwork Cells in a Transgenic Mouse Model of Glaucoma.Investigative ophthalmology & visual science · 2017Article
- A meta-analysis of neuroprotective effect for traditional Chinese medicine (TCM) in the treatment of glaucoma.Open medicine (Warsaw, Poland) · 2016Article
- Artificial Intelligence for Glaucoma: Creating and Implementing Artificial Intelligence for Disease Detection and Progression.Ophthalmology. GlaucomaArticle
- Strengthening institutional capacity for glaucoma care in sub-Saharan Africa.Middle East African journal of ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A significant proportion of glaucoma patients present late, particularly in the developing world, and unfortunately, in an advanced stage of the disease. They are at imminent danger of losing remaining vision, and may also be afflicted with various socioeconomic and health challenges. The encounter with such a patient is typically characterized by anxiety/fear and sometimes hopelessness from the patient's perspective. The physician may also feel that they are in a difficult position managing the patient's disease. When dealing with such cases, we suggest a holistic, individualized approach taking into account the 'biopsychosociospiritual' (BPSS) profile of each patient. The BPSS model takes into account relevant ocular as well as systemic biology (factors such as the mechanism of glaucoma, level of intraocular pressure [IOP], rate of progression, life expectancy, general health), psychological considerations (e.g., fear, depression), socio-economic factors and spiritual/cultural values and beliefs before being able to decide with the patient and their care partner(s) what treatment goals should be and how they can best be approached. Treatment for advanced glaucoma can be highly effective, and patients and their care partners should be informed that aggressive IOP lowering to the low teens or even single digits offers the best chance of protecting remaining vision. This can be achieved safely and effectively in most cases with trabeculectomy (including an antimetabolite), and in some cases with medical and/or laser therapy. Vision rehabilitation and psychosocial support should also be considered in order to optimize remaining vision, replace fear with hope as appropriate, and thus improve the overall quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.